BIOS-0620

N/A

Report date: 2024/03/26 13:28:30
NME

Base Information

Drug NameBIOS-0620
Drug Alias NameBIOS-0620
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha modulators
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Bio-Sincerity Pharma-Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Bio-Sincerity Pharma-Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A